XML 28 R19.htm IDEA: XBRL DOCUMENT v3.20.2
CB Oncology Partners (Tables)
 9 Months Ended
Sep. 30, 2020
CB Oncology Partners LLC [Member]  
Schedule of Equity Method Investments [Line Items]  
Equity Method Investment Summarized Financial Information
The following table presents the summarized financial information of CBOP:

CBOP Condensed Income Statement Information

  
Nine Months Ended
September 30,
(Unaudited)
 
       
  
2020
  
2019
 
       
Patient revenue
 
$
1,360,000
  
$
1,147,000
 
         
Net loss
 
$
(565,000
)
 
$
(882,000
)
         
USNC's equity in loss in CBOP
 
$
(148,000
)
 
$
(214,000
)

  
Three Months Ended
September 30,
(Unaudited)
 
       
  
2020
  
2019
 
       
Patient revenue
 
$
466,000
  
$
399,000
 
         
Net loss
 
$
(165,000
)
 
$
(309,000
)
         
USNC's equity in loss in CBOP
 
$
(48,000
)
 
$
(75,000
)

CBOP Condensed Balance Sheet Information

  
September 30,
2020
  
December 31,
2019
 
  
(Unaudited)
    
       
       
Current assets
 
$
470,000
  
$
380,000
 
         
Noncurrent assets
  
4,421,000
   
4,869,000
 
         
Total assets
 
$
4,891,000
  
$
5,249,000
 
         
Current liabilities
 
$
3,115,000
  
$
3,026,000
 
         
Noncurrent liabilities
  
3,820,000
   
4,019,000
 
         
Deficit
  
(2,044,000
)
  
(1,796,000
)
         
Total liabilities and deficit
 
$
4,891,000
  
$
5,249,000